Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1986 Apr;58(1):220–222. doi: 10.1128/jvi.58.1.220-222.1986

Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis.

A Löve, R Rydbeck, G Utter, C Orvell, K Kristensson, E Norrby
PMCID: PMC252897  PMID: 3754016

Abstract

A monoclonal antibody against the fusion (F) protein of mumps virus was found to confer marked protection in mumps virus-induced encephalitis. Almost total prevention of extensive brain necrosis was found. This study indicates that the virus F protein is directly involved in the pathogenesis of brain necrosis.

Full text

PDF
220

Images in this article

221Image
on p.221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buchmeier M. J., Lewicki H. A., Talbot P. J., Knobler R. L. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology. 1984 Jan 30;132(2):261–270. doi: 10.1016/0042-6822(84)90033-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Choppin P. W., Scheid A. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis. 1980 Jan-Feb;2(1):40–61. doi: 10.1093/clinids/2.1.40. [DOI] [PubMed] [Google Scholar]
  3. Johnson R. T., Johnson K. P. Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol. 1968 Oct;27(4):591–606. [PubMed] [Google Scholar]
  4. Kristensson K., Leestma J., Lundh B., Norrby E. Sendai virus infection in the mouse brain: virus spread and long-term effects. Acta Neuropathol. 1984;63(2):89–95. doi: 10.1007/BF00697190. [DOI] [PubMed] [Google Scholar]
  5. Lefrancois L. Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo. J Virol. 1984 Jul;51(1):208–214. doi: 10.1128/jvi.51.1.208-214.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Liddell F. D. Evaluation of survival in challenge experiments. Microbiol Rev. 1978 Mar;42(1):237–249. doi: 10.1128/mr.42.1.237-249.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Löve A., Rydbeck R., Kristensson K., Orvell C., Norrby E. Hemagglutinin-neuraminidase glycoprotein as a determinant of pathogenicity in mumps virus hamster encephalitis: analysis of mutants selected with monoclonal antibodies. J Virol. 1985 Jan;53(1):67–74. doi: 10.1128/jvi.53.1.67-74.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McCarthy M., Jubelt B., Fay D. B., Johnson R. T. Comparative studies of five strains of mumps virus in vitro and in neonatal hamsters: evaluation of growth, cytopathogenicity, and neurovirulence. J Med Virol. 1980;5(1):1–15. doi: 10.1002/jmv.1890050102. [DOI] [PubMed] [Google Scholar]
  9. Merz D. C., Wolinsky J. S. Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Virology. 1983 Dec;131(2):328–340. doi: 10.1016/0042-6822(83)90501-9. [DOI] [PubMed] [Google Scholar]
  10. Norrby E., Gollmar Y. Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect Immun. 1975 Feb;11(2):231–239. doi: 10.1128/iai.11.2.231-239.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Orvell C., Grandien M. The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus. J Immunol. 1982 Dec;129(6):2779–2787. [PubMed] [Google Scholar]
  12. Orvell C. The reactions of monoclonal antibodies with structural proteins of mumps virus. J Immunol. 1984 May;132(5):2622–2629. [PubMed] [Google Scholar]
  13. Parham P. On the fragmentation of monoclonal IgG1, IgG2a, and IgG2b from BALB/c mice. J Immunol. 1983 Dec;131(6):2895–2902. [PubMed] [Google Scholar]
  14. Rammohan K. W., McFarland H. F., McFarlin D. E. Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature. 1981 Apr 16;290(5807):588–589. doi: 10.1038/290588a0. [DOI] [PubMed] [Google Scholar]
  15. Schmaljohn A. L., Johnson E. D., Dalrymple J. M., Cole G. A. Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature. 1982 May 6;297(5861):70–72. doi: 10.1038/297070a0. [DOI] [PubMed] [Google Scholar]
  16. Wolinsky J. S., Stroop W. G. Virulence and persistence of three prototype strains of mumps virus in newborn hamsters. Arch Virol. 1978;57(4):355–359. doi: 10.1007/BF01320075. [DOI] [PubMed] [Google Scholar]
  17. Wolinsky J. S., Waxham M. N., Server A. C. Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol. 1985 Mar;53(3):727–734. doi: 10.1128/jvi.53.3.727-734.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES